Drug Information Association Logo
Corporate Tagline

The Impact of Drug Shortages on the Pharmaceutical Industry Part 4: Potential Policy Solutions to Solve Drug Shortage Problem

| Online

« Back to Listing

Overview 

Continuing Education Credits or Certificate Program units are not available for archived webinars.


Policy experts discuss various policy strategies and solutions which may be used to address drug shortage issues. Updates on relevant policies, including proposed legislation, is also discussed. Attendees will gain a greater appreciation and recognize factors that impacts drug shortages.

Archived Webinar available through June 5, 2013.

Who Should Attend 

Manufacturers, Distributers, Purchasing Organizations, Regulatory Bodies and Policy Makers

  • Regulatory Affairs
  • Clinical Safety/Pharmacovigilance
  • Pricing/Reimbursement
  • Public Policy/Law/Corp. Compliance
  • Quality Assurance/Quality Control
  • Strategic Planning
  • Sales and Marketing

Learning Objectives 

At the conclusion of this archived webinar, participants should be able to:

  • Discuss various policy strategies and solutions which may be used to address drug shortage issues
  • Recall updates on relevant policies, including proposed legislation
  • Identify the broader perspectives that impact drug shortages

Special Offers 

Save up to 20 percent by registering online in one transaction for multiple webinars in this series. (Special pricing valid for online registrations by individuals and groups.)

Contact Information 

For questions about Archived Webinars

Carolyn Callahan

DIA North America 

Phone +1.215.442.6194

Fax +1.215.442.6199

Carolyn.Callahan@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Presenter(s) 

Previous Next

Agenda  

Day 1 Wednesday, June 06, 2012

  • 7:00AM - 11:59PM

    The Impact of Drug Shortages on the Pharmaceutical Industry Part 4: Potential Policy Solutions to Solve Drug Shortage Problem

    Speaker(s):

    • Potential Policy Solutions to Address Drug Shortage Issues
      Daron Watts
      Sidley Austin Brown & Wood LLP, United States
    • Drug Shortages: FDA Regulatory and Policy Updates
      Denise Esposito
      Deputy Director for Policy, CDER
      FDA, United States

Registration Fees 

Other Fees

Government (Full Time) Individual
$125.00
Charitable Nonprofit/Academia Individual
$175.00
Group Site
$799.00
Group Plus
$995.00

Member

Member Individual
$250.00

Non-Member

NonMember Individual
$295.00
Register Online
« Back to Listing Back To Top